Yasushi Yatabe

Yasushi Yatabe

Auto-generated profile, based on publicly available information

Yasushi Yatabe

Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
WTWilliam D. Travis
William D. Travis
EBElisabeth Brambilla
Elisabeth Brambilla
MNMasayuki Noguchi
Masayuki Noguchi
ANAndrew G. Nicholson
Andrew G. Nicholson
KGKim R. Geisinger
Kim R. Geisinger
DYDavid Yankelewitz
David Yankelewitz

1 September 2015 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
WTWilliam D. Travis
William D. Travis
EBElisabeth Brambilla
Elisabeth Brambilla
ANAndrew G. Nicholson
Andrew G. Nicholson
YYYasushi Yatabe
Yasushi Yatabe
JAJohn H.M. Austin
John H.M. Austin
IWIgnacio Wistuba
Ignacio Wistuba

1 February 2010 in The Lancet Oncology
Verified
Journal Article
Closed access
TMTetsuya Mitsudomi
Tetsuya Mitsudomi
SMSatoshi Morita
Satoshi Morita
YYYasushi Yatabe
Yasushi Yatabe
SNShunichi Negoro
Shunichi Negoro
IOIsamu Okamoto
Isamu Okamoto
MFMasahiro Fukuoka
Masahiro Fukuoka

13 July 2015 in Nature
Verified
Journal Article
Open access
PDF file
JGJulie George
Julie George
JLJing Shan Lim
Jing Shan Lim
SJSe Jin Jang
Se Jin Jang
YCYupeng Cun
Yupeng Cun
LOLuka Ozretić
Luka Ozretić
RTRoman K. Thomas
Roman K. Thomas
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 and RB1, sometimes by complex genomic rearrangements. Two tumours with wild-type RB1 had evidence of chromothripsis leading to overexpression of cyclin D1 (encoded by the CCND1 gene), revealing an alternative mechanism of Rb1 deregulation. Thus, loss of the tumour suppressors TP53 and RB1 is obligatory in SCLC. We discovered somatic genomic rearrangements of TP73 that create an oncogenic version of this gene, TP73Δex2/3. In rare cases, SCLC tumours exhibited kinase gene mutations, providing a possible therapeutic opportunity for individual patients. Finally, we observed inactivating mutations in NOTCH family genes in 25% of human SCLC. Accordingly, activation of Notch signalling in a pre-clinical SCLC mouse model strikingly reduced the number of tumours and extended the survival of the mutant mice. Furthermore, neuroendocrine gene expression was abrogated by Notch activity in SCLC cells. This first comprehensive study of somatic genome alterations in SCLC uncovers several key biological processes and identifies candidate therapeutic targets in this highly lethal form of cancer.

1 June 2004 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JTJunichi Takamizawa
Junichi Takamizawa
HKHiroyuki Konishi
Hiroyuki Konishi
KYKiyoshi Yanagisawa
Kiyoshi Yanagisawa
STShuta Tomida
Shuta Tomida
HOHirotaka Osada
Hirotaka Osada
TTTakashi Takahashi
Takashi Takahashi
In this study, we report for the first time reduced expression of the let-7 microRNA in human lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative resection could be classified into two major groups according to let-7 expression in unsupervised hierarchical analysis, showing significantly shorter survival after potentially curative resection in cases with reduced let-7 expression (P = 0.0003). Multivariate COX regression analysis showed this prognostic impact to be independent of disease stage (hazard ratio = 2.17; P = 0.009). In addition, overexpression of let-7 in A549 lung adenocarcinoma cell line inhibited lung cancer cell growth in vitro. This study represents the first report of reduced expression of let-7 and the potential clinical and biological effects of such a microRNA alteration.

1 November 2005 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YHYoji Hayashita
Yoji Hayashita
HOHirotaka Osada
Hirotaka Osada
YTYoshio Tatematsu
Yoshio Tatematsu
HYHideki Yamada
Hideki Yamada
KYKiyoshi Yanagisawa
Kiyoshi Yanagisawa
TTTakashi Takahashi
Takashi Takahashi
MicroRNAs (miRNAs) are small noncoding RNAs, thought to be involved in physiologic and developmental processes by negatively regulating expression of target genes. We have previously reported frequent down-regulation of the let-7 miRNA family in lung cancers and, in the present study, assessed alteration in a panel of 19 lung cancer cell lines. As a result, we found for the first time that the miR-17-92 cluster, which comprises seven miRNAs and resides in intron 3 of the C13orf25 gene at 13q31.3, is markedly overexpressed in lung cancers, especially with small-cell lung cancer histology. Southern blot analysis revealed the presence of increased gene copy numbers of the miRNA cluster in a fraction of lung cancer cell lines with overexpression. In addition, we were able to show predominant localization of C13orf25 transcripts within the nucleus and introduction of the expression construct of the miR-17-92 cluster, but not the putative open reading frame of C13orf25, enhancing lung cancer cell growth. These findings clearly suggest that marked overexpression of the miR-17-92 cluster with occasional gene amplification may play a role in the development of lung cancers, especially in their most aggressive form, small-cell lung cancer, and that the C13orf25 gene may well be serving as a vehicle in this regard.